Evidence map›Paper›PMID 41170035›Full record

ArticleBioinformation2025

Electrocardiographic and biochemical profile of acute coronary syndrome in hospitalized COVID-19 patients.

Sandeep Aharwar, Rajat Kumar Tuteja, Pushpendra Singh Sengar, Dhruv Chowda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sandeep AharwarDepartment of Medicine, Atal Bihari Vajpayee Government Medical College, Vidisha, Madhya Pradesh, India.
Rajat Kumar TutejaDepartment of General Medicine, Dr. S.N. Medical College, Jodhpur, Rajasthan, India.
Pushpendra Singh SengarDepartment of Medicine, Bundelkhand Medical College & Hospital, Sagar, Madhya Pradesh, India.
Dhruv ChowdaDepartment of Medicine, LN Medical College & JK Hospital, Bhopal, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has been associated with the occurrence of acute coronary syndromes (ACS) and the medical and scientific communities consider the virus to put acute coronary syndromes (ACS) at risk because of its inflammatory and thrombotic effects. In a cross-sectional study of 100 hospitalized patients with COVID-19, 26 percent had ECG-confirmed ACS (16 percent STEMI/10 percent NSTEMI). The highest rates of elevated inflammatory and cardiac biomarkers occurred among older people, as well as diabetic and hypertensive patients. STEMI was substantially correlated to age >60 and increased fatality. It has become vital to detect cardiac involvement of COVID-19 at an early stage to diminish negative outcomes.

Indexed as

acute coronary syndrome (ACS)cardiac biomarkersCOVID-19CRPD-dimerinflammationmortalitynon-ST elevation myocardial infarction (NSTEMI)ST-elevation myocardial infarction (STEMI)Troponin-T

Identifiers

PMID41170035
PMCPMC12569938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.